NPC1 and hemophilia A: The susceptibility of many disease genes (such as DMD, ATM, NPC1 (Niemann-Pick disease), F9 (hemophilia A), F8 (hemophilia B)) to aberrant pre-mRNA splicing has spawned creative therapeutic approaches that have been the focus of a great deal of time and effort [77-84].